comprehensive -WSS

comprehensive

author：hotspot 2025-09-03 09:18:56 - browse：35

Holy Family Hospital in Methuen, Massachusetts. — Suzanne Kreiter/Boston Globe

Troubled hospital operator Steward Health Care, grappling with a financial crisis that’s engulfed its eight Massachusetts hospitals, has moved to shore up its finances by striking a deal to sell its nationwide physician network to insurance giant UnitedHealth’s Optum Care unit.

The proposed sale of the doctors group, called Stewardship Health, is part of Steward’s plan to bolster its national system of 33 hospitals after the Dallas-based company last year fell behind in paying bills and rents.

On Tuesday, a subsidiary of Optum, Collaborative Care Holdings, LLC, filed notice with the state’s Health Policy Commission over the sale. A price tag was not included in documents filed with the state, and Optum officials did not immediately respond to comment.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Why health care costs have stayed mostly flat since 2010

knowledge

WSS

SEC charges former device maker CEO with $41 million fraud

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Bristol Myers buys into radiopharmaceuticals with RayzeBio

SEC charges former device maker CEO with $41 million fraud

David Ricks of Eli Lilly: best biopharma CEO of 2023

SNAP should offer more nutrition education

explore

comprehensive

focus

Psychedelics group wrestles with new pharma identity

Harvard scientists, with Google, unveil the most detailed brain map ever

What does generative AI mean for health care? We asked experts

Insurer loopholes limit power of law against surprise medical bills

ChatGPT in medicine: STAT answers readers' burning questions

Mass General Brigham physicians react to latest merger step

Novavax promises a turnaround & Lilly roils the obesity market

U.K. decision on ALS drug has neurologists, advocates up in arms

Moonlake's readout produced a cash windfall. Risks remain

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

focus

Trial using CRISPR to edit HIV out of cells disappoints

Young boy dies in trial for Pfizer Duchenne gene therapy

Keeping primary care docs in field isn't impossible, says AAFP CEO

Bristol Myers buys into radiopharmaceuticals with RayzeBio

CRISPR gene editing developments we’re watching in 2024

Bird flu in dairy cattle: New measures to control spread to humans

explore

knowledge

leisure time

focus